| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Oncotelic Therapeutics, Inc. | Chief Clin. Ops. Officer, Director | Stock Options | 600,000 | 03 Sep 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| OTLC | Oncotelic Therapeutics, Inc. | 03 Sep 2021 | 1 | $0 | 4 | Chief Clin. Ops. Officer, Director | 08 Sep 2021, 17:00 |
| OTLC | Oncotelic Therapeutics, Inc. | 31 Mar 2021 | 3 | $0 | 4 | CHIEF CLINICAL OFFICER, Director | 16 Jul 2021, 17:39 |